Vericel Prices $65MM Public Offering of Stock
Vericel, developer of MACI® autologous cultured chondrocytes for cartilage repair, priced its underwritten public offering of 5MM shares of common stock at $13/share....
Vericel, developer of MACI® autologous cultured chondrocytes for cartilage repair, priced its underwritten public offering of 5MM shares of common stock at $13/share....
Medartis raised a total of CHF 142.6MM, including an over-allotment of shares, in its IPO. Funds will support the company's...
Biorez closed a US $1.5MM funding and affirmed plans for 2019 launch of human clinical studies with a scaffold that may eliminate the need to...
Micro C Imaging, developer of a portable extremity imaging system, has increased its seed investment to US $2.2MM. ...
Simplify Medical closed an additional US $23.3MM in a Series B financing, for a total $44.3MM raised. Funds will support...
7D Surgical secured funding to support launch of the Machine-vision Image Guided Surgery system for spinal surgery navigation....
CartiHeal gained an investment of $2.5MM from Bioventus to support the IDE trial of the Agili-C cartilage regeneration implant....
Conventus Orthopaedics closed a US $12MM venture loan. Funds will support commercialization of Nitinol-based cage technology, used to treat periarticular...
Articulus Bio received an undisclosed amount of funding that will support development of a total ankle replacement specifically addressing the issue of...
Numerate, a drug design company, was awarded a grant by NIAMS to investigate compounds for surface coating of orthopaedic implants....
Login
Register for a free account
As a guest member you get access to more articles and videos every month.